Compile Data Set for Download or QSAR
Report error Found 12 Enz. Inhib. hit(s) with all data for entry = 8600
TargetALK tyrosine kinase receptor(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406408(US10336734, Example 21)
Affinity DataIC50: 2nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetALK tyrosine kinase receptor(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406407(US10336734, Example 20)
Affinity DataIC50: 7nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetActivated CDC42 kinase 1(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406408(US10336734, Example 21)
Affinity DataIC50: 24nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetActivated CDC42 kinase 1(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406407(US10336734, Example 20)
Affinity DataIC50: 27nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetALK tyrosine kinase receptor(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406409(US10336734, Example 26)
Affinity DataIC50: 34nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetActivated CDC42 kinase 1(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406409(US10336734, Example 26)
Affinity DataIC50: 39nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406408(US10336734, Example 21)
Affinity DataIC50: 860nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406409(US10336734, Example 26)
Affinity DataIC50: 1.08E+3nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406407(US10336734, Example 20)
Affinity DataIC50: 1.72E+3nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406408(US10336734, Example 21)
Affinity DataIC50: 8.25E+3nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406407(US10336734, Example 20)
Affinity DataIC50: 1.15E+4nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase Src(Human)
H. Lee Moffitt Cancer Center and Research Institute

US Patent
LigandPNGBDBM406409(US10336734, Example 26)
Affinity DataIC50: 1.68E+4nMAssay Description:Enzyme-Linked Immunosorbent Assay.More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/21/2020
Entry Details
US Patent